| abstract |
The present invention relates to topical formulations comprising a compound of the general formula: for use in the treatment of ocular neovascularization. The compound-I is present in a solution or suspension at a concentration of about 0.005% to about 5.0% w/v such that the solution or suspension delivers the compound to the posterior segment of the eye for use in the retina and/or choroid VEGF, |